Kyinsu
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Kyinsu, covering 2026-02-12 to 2026-02-12. Get the full timeline:
Most recent: EMA Authorised: Kyinsu (insulin icodec;semaglutide) — Novo Nordisk A/S
1 regulatory and trial event tracked for Kyinsu, covering 2026-02-12 to 2026-02-12. Get the full timeline:
Most recent: EMA Authorised: Kyinsu (insulin icodec;semaglutide) — Novo Nordisk A/S